TPTX » Topics » AXONYX ANNOUNCES LICENSE OF PHENSERINE TO DAEWOONG PHARMACEUTICAL COMPANY FOR SOUTH KOREA

This excerpt taken from the TPTX 8-K filed Jan 6, 2006.

AXONYX ANNOUNCES LICENSE OF PHENSERINE TO DAEWOONG
PHARMACEUTICAL COMPANY FOR SOUTH KOREA

NEW YORK, NY – January 4, 2006 – Axonyx Inc. (NASDAQ: AXYX) announced today that it has granted to Daewoong Pharmaceutical Company Ltd. (Daewoong) an exclusive license for the use of Phenserine in the South Korean market. Under the terms of the agreement Daewoong, at its own costs, undertakes to pursue the product development and regulatory work necessary for a New Drug Application (NDA) (or its equivalent) in South Korea with respect to Phenserine for the treatment of Alzheimer’s disease (AD).

The financial terms of the deal are confidential, but include royalty payments to Axonyx based on sales of Phenserine by Daewoong in the South Korean market.

This license arrangement is part of the Company’s previously announced strategy to identify partners that are able and willing to commit the necessary financial resources to Phenserine’s further development and marketing approval.

“We are excited about this license agreement which is our first for Phenserine. We expect Daewoong to build on the significant clinical data we have generated as they continue the development of Phenserine,” stated Gosse Bruinsma, M.D., President and CEO of Axonyx.

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki